Skip to main content

New ruleMedicare agency (CMS)

New federal organ rule spells out a rare harm: disease passed from donor to patient

A rule for the organizations that recover donor organs lists disease passed from a donor to a recipient, including cancer, among the adverse events they must have policies to identify and prevent.

Narration voice and music are AI-generated.

On November 3, 2026, the Centers for Medicare & Medicaid Services (CMS) published a final rule that revises the federal requirements for the organizations that recover organs from deceased donors.1 It takes effect on January 4, 2027.1 Much of the rule concerns competition.1 CMS estimates that 35 of the country's 55 donation service areas will be opened to competition during the recertification cycle.1

For transplant patients who were harmed, and for the lawyers who represent them, a quieter part of the rule matters more. Among the adverse events these organizations must have policies to identify, report and prevent, it lists disease passed from a donor to the person who receives the organ, including the spread of cancer.12 Unexpected cases are rare.3 When one happens, it raises hard questions about what the donor's screening showed, who was told, and how fast.

A system under new scrutiny

Each donation service area has one organ procurement organization (OPO), which secures authorization for donation, recovers organs and coordinates their delivery for transplantation.14 In this region, Gift of Life Donor Program says it serves the eastern half of Pennsylvania, southern New Jersey and Delaware;5 the Center for Organ Recovery & Education (CORE), based in Pittsburgh, says it covers western Pennsylvania, West Virginia and Chemung County, New York;6 and NJ Sharing Network describes itself as New Jersey's federally designated OPO.7

CMS grades each area on two rates, donation and transplantation.2 CMS estimates from updated performance data that 14 areas are in tier 3, the lowest, and 21 are in tier 2.12 An OPO whose areas are all in tier 3 will be decertified, while one with tier 2 areas must compete to keep them.2

Schematic. No real OPO, rate or benchmark value is plotted.

How CMS sorts a donation service area into tiers

The point is one donation service area (DSA). Drag it, tap the plane, or use the two sliders. The outcome measures focus on two rates, the donation rate and the transplantation rate.src

Tier 3: The transplantation rate is below the lower benchmark. One measure below is enough.

“OPOs with tier 3 DSAs are the lowest performing OPOs with one or both measures below the lower benchmark.”src

What tier 3 means

  • An OPO loses its designation to any service area placed in tier 3 in the final assessment period.1
  • OPOs that only have tier 3 service areas will be decertified and cannot compete for any other open area.src
  • Competition for tier 3 service areas begins once any administrative appeals have been exhausted.1

“OPOs with tier 3 DSAs in the final assessment period will have designation to those DSAs removed as specified at Sec. 486.316(a)(3).”

Final rule, Federal Register document 2026-223811

The tier 3 description, which this point does not fit: “OPOs with tier 3 DSAs are the lowest performing OPOs with one or both measures below the lower benchmark.”src

If the area is in tier 2

  • OPOs with tier 2 service areas are eligible for recertification but must compete to keep those areas.src

“OPOs with DSAs that are in tier 2 are also eligible for recertification but must compete to retain their DSAs.”

CMS fact sheet on the final rulesrc

The drawing shows only the lower benchmark. The CMS fact sheet also describes an upper benchmark, which separates tier 1 from tier 2.src

Each donation service area is assigned to tier 1, tier 2 or tier 3, based on performance on the outcome measures for the final assessment period.1 CMS says the rule does not change the tier structure used to recertify and decertify OPOs.1

CMS's estimate from updated performance data1

14areas in tier 3

21areas in tier 2

about35open for competition

CMS says the figure “is not an estimate that 35 OPOs will be de-certified or that all 35 open DSAs will transition to a different OPO.”1 The 21 tier 2 service areas are open for competition but do not involve decertification.1

For scale: The 54 OPOs serve 55 donation service areas, because one OPO serves more than one area.1

The rule's dates

  1. CMS announces the final rulesrc
  2. Published in the Federal Register1
  3. The rule takes effect1
  4. Current OPO agreements end1

The rule is Federal Register document 2026-22381.1 CMS may extend agreements past that date if needed to finish appeals and competitions and to hand over a service area in an orderly way.1

Each area lands in tier 1, 2 or 3 based on its performance on these measures.1
What this shows
How the tier 3 description works on the two rates: one measure below the lower benchmark places an area in tier 3 territory. Also CMS's own count of areas open for competition, and the rule's dates.
What it does not show
Any real OPO, rate or benchmark value: the positions are schematic and the axes carry no numbers. It does not place any Pennsylvania or New Jersey OPO in a tier. It shows only the lower benchmark; the CMS fact sheet also describes an upper benchmark, which separates tier 1 from tier 2.src

CMS has already moved to decertify two organizations outside this region: Life Alliance Organ Recovery Agency, in Miami, and Network for Hope, in Louisville, Kentucky.8910 Network for Hope's decertification now takes effect June 4, 2027.9 None of the notices says which requirement was not met.1011

When the transplant itself makes a patient sick

The transplant system acknowledges that screening has limits.12 Under the policies of the Organ Procurement and Transplantation Network (OPTN), transplant programs must tell candidates that no screening catches every transmissible disease, and that cancer and disease may pass from a donor.12

From 2008 through 2017, the OPTN's Disease Transmission Advisory Committee received 2,185 reports, and 335 (15%) were classified as proven or probable transmissions from a donor.3 Infections were the most common, at 67%, followed by cancers, at 29%.3 In the same study, unexpected donor-derived disease occurred in 0.18% of transplant recipients.3 In UK data from 2001 to 2010, 18 recipients developed cancers of donor origin from the organs of 16 of 14,986 deceased donors, and none of the donors from whom cancer was transmitted was known to have cancer at donation.13

When it does happen, it can be grave. A systematic review gathered 73 published cases of cancer transmitted from a donor in liver, heart, lung and multi-organ recipients.14 The median time to diagnosis was 8 months, and 42% of the cancers had already spread widely when they were found.14 Mortality was 75%, and median survival was 7 months.14 The authors caution that publication bias limits the evidence.14 For kidney or pancreas recipients, stopping immune-suppressing drugs and removing the organ can lead to remission.14

Risks of cancer transmission must be balanced against the risks of dying without transplantation.”13

UK transplant safety guidance.13

What the rules require when it happens

Under OPTN policy, the duties start before surgery: a transplant program must explain these risks, obtain informed consent and document it in the medical record.12 After recovery, the OPO must report every positive donor test result to each program that received the donor's organs within 24 hours of receiving it.12 If the OPO is notified that a recipient is suspected to have, has, or died from a disease and there is substantial concern that it came from the organ, the OPO must share the results with every program and tissue bank that received organs or tissue from that donor within 24 hours of receiving them.12 When a transplant program finds an unexpected disease or cancer in the donor's test results, it must tell its recipients of the risk and follow them for signs of the disease.12 When a recipient is suspected of such a disease and there is substantial concern that it came from the organ, the program must report it through the OPTN Patient Safety Reporting Portal within 24 hours of learning of it.12

The rule keeps the definition of an adverse event that CMS adopted in 2006: "an untoward, undesirable, and usually unanticipated event that causes death or serious injury or the risk thereof".1 That definition already gives transmission of disease from a donor as an example.1 The rule moves the examples to a new list at 42 C.F.R. § 486.348(c)(3), which from January 4, 2027 names malignancies (cancer) outright: transmission of a disease from a donor to an organ recipient, "such as the transmission, dissemination, and seeding of malignancies".1

Why injury lawyers are watching

Pennsylvania's anatomical gift law, at 20 Pa.C.S. § 8616(c), says a person who acts in good faith under it is not liable for damages in a civil action for that act.15 That protection does not extend to gross negligence, recklessness or intentional misconduct.15 Whether it applies in a given case is a legal question. Either way, the records matter: what the donor's history and tests showed, who received the results, and when.

Timing matters too: a transmitted cancer can surface months later.14 In Pennsylvania, an action for injuries caused by the negligence of another generally must be commenced within two years.16 The Supreme Court of Pennsylvania has explained that the discovery rule tolls (pauses) that period where a plaintiff is reasonably unaware of the injury and that another party's conduct caused it.17 New Jersey also generally sets a two-year limit for injury claims.18 Shorter deadlines can apply to some claims, for example claims against public hospitals. When the clock starts in a particular case is a question for a lawyer.

If you were told of a disease that may have come from your donor, keep every notice and ask the program in writing for your records. The companion explainer, Cancer from a donor organ: what transplant patients should know, covers the rules and deadlines in more detail.

Questions about how this affects you?

If you or someone in your family was hurt and you want to understand your options, you can talk with a lawyer at CM Injury at (267) 936-2233. The conversation is free and confidential.

Sources

  1. Federal Register final rule 2026-22381 (91 FR 69390), full text: OPO Conditions for Coverage revisionsFederal RegisterRetrieved November 10, 2026
  2. CMS fact sheet: OPO Conditions for Coverage revisions final rule (CMS-3409-F)Centers for Medicare & Medicaid ServicesRetrieved November 10, 2026
  3. Kaul DR et al., Ten years of donor-derived disease: A report of the Disease Transmission Advisory Committee, Am J Transplant 2021;21:689-702 (copy in WHO NOTIFY Library)notifylibrary.orgRetrieved November 10, 2026
  4. CMS press release: CMS finalizes rule to help more organs reach patientsCenters for Medicare & Medicaid ServicesRetrieved November 10, 2026
  5. Gift of Life Donor Program: overviewdonors1.orgRetrieved November 10, 2026
  6. CORE brochure, A Partner For Life, page 3core.orgRetrieved November 10, 2026
  7. NJ Sharing Network: aboutnjsharingnetwork.orgRetrieved November 10, 2026
  8. CMS notice (revised): Life Alliance Organ Recovery Agency de-certification (December 15, 2025)Centers for Medicare & Medicaid ServicesRetrieved November 10, 2026
  9. CMS revised notice: Network for Hope de-certification (November 2, 2026)Centers for Medicare & Medicaid ServicesRetrieved November 10, 2026
  10. CMS notice: Network for Hope decertificationCenters for Medicare & Medicaid ServicesRetrieved November 10, 2026
  11. CMS notice: Life Alliance Organ Recovery Agency de-certification (September 18, 2025)Centers for Medicare & Medicaid ServicesRetrieved November 10, 2026
  12. OPTN Policies PDF (Internet Archive capture of hrsa.gov/sites/default/files/hrsa/optn/optn_policies.pdf)web.archive.orgRetrieved November 10, 2026
  13. UK SaBTO guidance: Transplantation of organs from deceased donors with cancer or a history of cancerassets.publishing.service.gov.ukRetrieved November 10, 2026
  14. Systematic review, PMC8842379ncbi.nlm.nih.govRetrieved November 10, 2026
  15. 20 Pa.C.S. § 8616 (Rights and duties at death), palegis.us official textPennsylvania General Assembly (palegis.us)Retrieved November 10, 2026
  16. 42 Pa.C.S. § 5524 (Two year limitation), palegis.us official textPennsylvania General Assembly (palegis.us)Retrieved November 10, 2026
  17. Nicolaou v. Martin, No. 44 MAP 2017 (Pa. 2018), majority opinion (pacourts.us)Unified Judicial System of Pennsylvania (pacourts.us)Retrieved November 10, 2026
  18. N.J.S.A. 2A:14-2 (lis.njleg.state.nj.us, official NJ statutes)New Jersey LegislatureRetrieved November 10, 2026

Attorney Advertising. CM Injury (Cavaliere & Mangiaracina, PLLC), 161 Washington Street, Suite 1010, Conshohocken, PA 19428. Reviewed by Frank Mangiaracina. (267) 936-2233.

This article is general information, not legal advice, and reading it does not create an attorney-client relationship. Laws change and every case turns on its own facts.

Images: Illustration.

How we report: our sources, fact-checking and corrections.

We Win Big
Tell Us What Happened

Free, no obligation.